CVS Plans to Break Up $117 Billion Healthcare Conglomerate
Summary
Bloomberg Intelligence analyzes CVS Health's surprise decision to spin off its retail pharmacy business, questioning the strategic logic behind the move and noting the market's negative reaction. The episode also features Mandeep Singh discussing how recent election results in Texas may slow data center construction, potentially lowering 2027 CapEx for hyperscalers. Additionally, the team reviews recent earnings from Uber, highlighting rising R&D costs and pricing pressures, and contrasts AMD's strong performance against Intel's struggles in the AI chip market.
Topics discussed
Survey: Financial advisors expect private market growth
Bloomberg Tech Minute: SpaceX hiring culture and Musk loyalty
Sponsor: Cincinnati Insurance and planning for the future
Podcast introduction and listening options
CVS spins off retail pharmacy: History and rationale
Impact on rivals and potential new partnerships
Market reaction and questions on deal economics
Bloomberg Tech Minute: The gray market for peptides
Bloomberg Market Minute: Stock records vs. rising costs
Podcast introduction and listening options
Tech sector: AI data center capex and election impacts
Uber earnings: AV investments and pricing pressures
AMD vs Intel: AI chip demand and execution contrast
Podcast promotion and availability
Sponsor: Empower Personal Dashboard
Sponsor: ChatGPT for productivity and planning
Sponsor: Underdog digital card packs
Listen ad-free on Castria